Mackenzie Financial Corp United Therapeutics Corp Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
A detailed history of Mackenzie Financial Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,848 shares of UTHR stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,848
Previous 15,263
81.34%
Holding current value
$1.04 Million
Previous $4.86 Million
79.02%
% of portfolio
0.0%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding UTHR
# of Institutions
673Shares Held
42.2MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.61 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.16 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$817 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...